Skip to main content
. 2017 Jan 11;7:40467. doi: 10.1038/srep40467

Figure 2. Dose- and time-dependent effects of HIV-1 gp120, METH and NT on the Aβ (1–42) release in HBMECs cultures.

Figure 2

The Aβ (1–42) immunoreactivity was measured in CS samples collected from HBMECs cultures during the continuous exposure (1–96 h) to 50 ng/ml gp120 or vehicle (n = 6 per group). (a) 50 ng/ml gp120 (1–96 h); (b) 50 nM METH (1–96 h); (c) 10 μM NT (1–96 h); and (d) 0–200 ng/ml gp120 (24 h). Data are presented as mean values ± SEM. **Marks significant (P < 0.01) differences in Aβ (1–42) immunoreactivity between gp120- or METH/NT-treated and vehicle-treated cell cultures.